GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Wuxi AppTec Co Ltd (SHSE:603259) » Definitions » 14-Day RSI

Wuxi AppTec Co (SHSE:603259) 14-Day RSI : 37.18 (As of Apr. 22, 2025)


View and export this data going back to 2018. Start your Free Trial

What is Wuxi AppTec Co 14-Day RSI?

The Relative Strength Index (RSI) is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100. Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30.

As of today (2025-04-22), Wuxi AppTec Co's 14-Day RSI is 37.18.

The industry rank for Wuxi AppTec Co's 14-Day RSI or its related term are showing as below:

SHSE:603259's 14-Day RSI is ranked better than
78.11% of 233 companies
in the Medical Diagnostics & Research industry
Industry Median: 45.52 vs SHSE:603259: 37.18

Competitive Comparison of Wuxi AppTec Co's 14-Day RSI

For the Diagnostics & Research subindustry, Wuxi AppTec Co's 14-Day RSI, along with its competitors' market caps and 14-Day RSI data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Wuxi AppTec Co's 14-Day RSI Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Wuxi AppTec Co's 14-Day RSI distribution charts can be found below:

* The bar in red indicates where Wuxi AppTec Co's 14-Day RSI falls into.


;
;

Wuxi AppTec Co  (SHSE:603259) 14-Day RSI Calculation

The formula for calculating RSI is:

RSI=100[ 100 / ( 1 + Average Gain / Average Loss )]

* Note that the formula uses a positive value for the average loss.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Wuxi AppTec Co  (SHSE:603259) 14-Day RSI Explanation

The Relative Strength Index (RSI), developed by J. Welles Wilder in his book “New Concepts in Technical Trading Systems.”, is a momentum oscillator that measures the speed and change of price movements. The RSI is most typically used on a 14-day period, measured on a scale from 0 to 100.

Traditionally, an asset is considered overbought or overvalued when the RSI is above 70 and oversold or undervalued when it is below 30. A RSI surpasses the 30 level indicates a bullish sign, when it slides below 70 level, it’s a bearish sign. This level can be adjusted depending on the security’s pattern and the market’s underlying trend. In an uptrend or bullish market, the RSI might range within a higher interval, investors could set the support level higher. If a downtrend or bearish market occurs, investors may need to lower the resistance level.

RSI can also be used in trading techniques to indicate the trading signal, such as Divergences and Swing Rejections.


Wuxi AppTec Co 14-Day RSI Related Terms

Thank you for viewing the detailed overview of Wuxi AppTec Co's 14-Day RSI provided by GuruFocus.com. Please click on the following links to see related term pages.


Wuxi AppTec Co Business Description

Traded in Other Exchanges
Address
288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Pudong New Area, Shanghai, CHN, 200131
Wuxi AppTec Co Ltd provides a portfolio of research and manufacturing services throughout the discovery, development, and manufacturing spectrum for small molecule drugs, development of computer software and databases as well as consulting services for combinatorial chemistry and pharmaceuticals. The services offered by the company include drug research and development testing, clinical research services, an end-to-end CRDMO platform for peptide, oligonucleotide, and small molecules, and integrated biology services and solutions for drug discovery. The company's reportable segments are WuXi Chemistry, which derives maximum revenue, WuXi Testing, WuXi Biology, and Others. Geographically, it derives key revenue from the United States of America, followed by China, Europe, and other regions.
Executives
Chen Shu Hui senior management
Yang Director
Hu Zheng Guo Director
senior management
Yao Chi Director
Chen Min Director
Zhu Bi Xin senior management
Yang senior management
Chen Shu Hui senior management
Hu Zheng Guo Director

Wuxi AppTec Co Headlines

No Headlines